Trial intelligence / Profile preview

Tranexamic Acid vs Q-switched KTP Laser for Freckles

NCT03885895Phase 1Unknown

Sponsor
Kasr Al Ainy Hospital
Start
Jan 2019
Primary completion
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, single-blind trial of tranexamic acid in ephelides, sponsored by Kasr Al Ainy Hospital. Primary endpoints: Pigmentation and Severity Index at 1 year and Melanin Index at 1 year. Status: unknown.

02

Drugs

tranexamic acid
03

Conditions

ephelides

Beyond the preview

Go deeper on NCT03885895.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03885895.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call